semaglutide increases risk of what Tirzepatide vs. Semaglutide: You Should Know Taking the next step: the

If results remain positive, Eli Lilly is projected to submit a New Drug Application to the FDA in late 2026, with potential approval in the first half of 2027

However, it is important to consult a healthcare professional before starting semaglutide treatment to ensure safety and efficacy

Retatrutide, a drug researched for obesity and metabolic concerns, has been associated with skin laxity in trials

The differentiator is pathway-level genetic insight that maps FTO, GLP1R, and MC4R variants context not offered at Hers, Noom, or most other GLP-1 telehealth programs

Gastrointestinal (digestive tract) side effects are the most common side effects for both Mounjaro and Ozempic, and incretin mimetics in general